Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance

The correlation of sVEGFR-2 with insulin resistance supports the need for further investigations to define the clinical utility and predictive value of serum sVEGFR-2 levels in cardiovascular dysfunction in MetS.